KYMRIAH 1.2 x 1 000 000 - 6 x 100 000 000 cells, dispersion for infusion bag, 50 ml
Active ingredients: Tisagenlecleucel
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for infusionbag, 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KYMRIAH 1,2 x 1 000 000 - 6 x 100 000 000 cellules, dispersion pour perfusion
- Pharmaceutical form
- dispersion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- poche(s) EVA : éthylène vinyl acétate copolymère suremballée(s)/surpochée(s) avec matériel(s) de perfusion - maximum de 50 ml en fonction du patient - 1 ou plusieurs poches
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Mar 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65647882CIP75505781CIP133400955057819Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TISAGENLECLEUCELdispersion | 1,2 x 1 000 000 à 6 x 100 000 000 lymphocytes · 1 à 3 poches | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.